Senner Christopher J.
Transaction: 06/11/2026
BUY
Change
+2,700
Price
$0.95
Filing
06/15/2026
Type
BUY
Quince Therapeutics, Inc.
QNCX • Biotechnology
$31.32
▲ +0.77 (+2.52%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$192.08M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.53Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:18 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$31.32
Change2.52%
Shares Out6.13M
Market Cap$192.08M
Enterprise Value$76.10M
52W Range15.10 - 910.00
Beta1.40
P/E-2.08
P/B-5.44
P/FCF-4.09
EV/EBITDA-0.64
EV/FCF-1.62
Price$31.32
Change2.52%
Shares Out6.13M
Market Cap$192.08M
Enterprise Value$76.10M
52W Range15.10 - 910.00
Beta1.40
P/E-2.08
P/B-5.44
P/FCF-4.09
EV/EBITDA-0.64
EV/FCF-1.62
Earnings Yield-48.14%
FCF Yield-24.47%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.51
Current Ratio0.53
Quick Ratio0.53
Target$69.00
Target Upside120.31%
Target Median$69.00
Target Range68.00 - 70.00
Volume25.93K
Avg Volume56.48K
EPS Surprise0.71
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Weak liquidity · 0.53Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 11 analyst votes · 2026-09-05
59/100
Neutral
Bullish
4
Hold
5
Bearish
2
Price Target
2026-09-05
Low
$68.00
Mean
$69.00
Median
$69.00
High
$70.00
Insider Transactions
Recent executive and insider activity
⚠ 2 high-volume insider sells detected
Lamond David
Transaction: 06/11/2026
BUY
Change
+2,700
Price
$0.95
Filing
06/15/2026
Type
BUY
Roberts Brigette
Transaction: 05/18/2026
OTHER
Change
0
Price
Not reported
Filing
06/11/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Senner Christopher J. | BUY | +2,700 | $0.95 | 06/11/2026 | 06/15/2026 |
| Lamond David | BUY | +2,700 | $0.95 | 06/11/2026 | 06/15/2026 |
| Roberts Brigette | OTHER | 0 | Not reported | 05/18/2026 | 06/11/2026 |
| Roberts Brigette | BUY | +34,675 | $0.09 | 05/18/2026 | 06/11/2026 |
| Hannah Brendan | SELL | -365,000 | $3.08 | 01/23/2026 | 01/23/2026 |
| Ryan Charles S. | BUY | +200,000 | $3.08 | 01/23/2026 | 01/23/2026 |
| Thye Dirk | BUY | +1,000,000 | $3.08 | 01/23/2026 | 01/23/2026 |
| Bray June | BUY | +18,724 | $3.00 | 01/02/2026 | 01/21/2026 |
| Lamond David | BUY | +29,423 | $3.00 | 01/02/2026 | 01/21/2026 |
| McLoughlin Margaret | BUY | +19,547 | $3.00 | 01/02/2026 | 01/21/2026 |
| Senner Christopher J. | BUY | +21,810 | $3.00 | 01/02/2026 | 01/21/2026 |
| Benatti Luca | SELL | -50,000 | $3.47 | 12/26/2025 | 12/29/2025 |
| Benatti Luca | BUY | +8,918 | Not reported | 10/23/2024 | 12/29/2025 |
| Thye Dirk | SELL | -739,885 | Not reported | 12/10/2025 | 12/12/2025 |
| Hannah Brendan | SELL | -2,271 | $0.55 | 12/05/2025 | 12/08/2025 |
| Hannah Brendan | BUY | +2,271 | $0.55 | 12/05/2025 | 12/08/2025 |
| Thye Dirk | BUY | +150,944 | $1.20 | 06/18/2025 | 06/23/2025 |
| Thye Dirk | BUY | +150,944 | $1.20 | 06/18/2025 | 06/23/2025 |
| Ryan Charles S. | BUY | +7,548 | $1.20 | 06/18/2025 | 06/23/2025 |
| Ryan Charles S. | BUY | +7,548 | $1.20 | 06/18/2025 | 06/23/2025 |